Products
16736 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 89.87 | 3.79 | 0.020 | 3.81 | 1 | -3.32% | 6.16% | -64.45% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 89.87 | 10.88 | 0.360 | 11.24 | 1 | -13.58% | ― | 20.62% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 89.87 | 0.62 | 0.010 | 0.63 | 1 | -6.06% | 14.81% | -94.52% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 89.87 | 10.77 | 0.120 | 10.89 | 1 | -10.32% | ― | 19.27% | 12 May. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 435.652 | 0.15 | 0.010 | 0.16 | 1 | -6.25% | -6.25% | -98.91% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1346000271 | Novo Nordisk | Constant Leverage | Long | ― | 435.652 | 0.068 | 0.001 | 0.069 | 1 | 17.24% | 15.25% | -99.44% | 9 Jul. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1396328325 | Novo Nordisk | Constant Leverage | Long | ― | 435.652 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | -99.99% | 12 Feb. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 435.652 | 0.01 | ― | ― | 1 | 900.00% | 900.00% | -99.92% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 435.652 | 0.009 | ― | ― | 1 | 800.00% | 800.00% | -99.93% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1396327897 | Novo Nordisk | Constant Leverage | Long | ― | 435.652 | 0.093 | 0.001 | 0.094 | 1 | 16.25% | 9.41% | -99.23% | 29 Jan. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1396327889 | Novo Nordisk | Constant Leverage | Long | ― | 435.652 | 0.56 | 0.010 | 0.57 | 1 | 1.82% | -1.75% | -95.39% | 29 Jan. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1396327905 | Novo Nordisk | Constant Leverage | Long | ― | 435.652 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | -99.99% | 29 Jan. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 435.652 | 9.42 | 0.040 | 9.46 | 1 | -4.07% | -3.09% | -20.84% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 435.652 | 1.87 | 0.010 | 1.88 | 1 | -5.56% | -5.56% | -85.85% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993000 | Novo Nordisk | Constant Leverage | Short | ― | 435.652 | 0.017 | 0.001 | 0.018 | 1 | 70.00% | 70.00% | -99.87% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1423415707 | Novo Nordisk | Constant Leverage | Short | ― | 435.652 | 12.26 | 0.100 | 12.36 | 1 | -7.89% | -9.52% | 6.79% | 7 May. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1119068000 | Nvidia | Constant Leverage | Long | ― | 134.221 | 63.26 | 0.130 | 63.39 | 1 | -4.04% | 64.61% | 601.33% | 12 May. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1199369815 | Nvidia | Constant Leverage | Long | ― | 134.221 | 7.78 | 0.020 | 7.8 | 1 | -5.01% | 83.06% | -12.19% | 27 Jun. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1246614460 | Nvidia | Constant Leverage | Long | ― | 134.221 | 1.04 | 0.010 | 1.05 | 1 | -6.31% | 96.23% | -86.53% | 3 Feb. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1246615640 | Nvidia | Constant Leverage | Long | ― | 134.221 | 0.2 | 0.010 | 0.21 | 1 | -9.09% | 100.00% | -98.10% | 8 Jun. 2023 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.